Case report: A novel HNF1A variant linked to gestational diabetes, congenital hyperinsulinism, and diazoxide hypersensitivity
Front Endocrinol (Lausanne). 2024 Oct 3;15:1471596. doi: 10.3389/fendo.2024.1471596. eCollection 2024. ABSTRACT Diazoxide (DZX) remains the first-line medication for the treatment of prolonged and persistent forms …